United States
US 12,697,317 B2
Dosages and uses of ornithine phenylacetate for treating hyperammonemia
US 12,697,317 B2 is a granted patent from the United States Patent and Trademark Office (USPTO), dated 2026-08-04. Applicant: AMALIVE LIMITED. Its PDF downloads from this page without an account, up to 5 a day.
- Applicant
- AMALIVE LIMITED
- Inventors
- Xiaofeng Wang Rears; Jack Tseng; Carmen Mak; Nagaraju Poola; Regis Vilchez; Aniruddha Potnis; Susan VanMeter; Jan Stange
- Publication date
- 2026-08-04
- Filing date
- 2022-04-06
- Document type
- B2 Granted patent
- Also written as
- US 12,697,317 B2 · US12697317 · 12697317
Abstract
Embodiments of the present disclosure relate to doses of ornithine phenylacetate for treating or ameliorating hyperammonemia and the methods of administrating the same in a patient with a chronic liver disease, for example, cirrhosis. In some embodiments, the patient also has hepatic encephalopathy as a complication of the liver disease.
The opening of the abstract. The full text is in the PDF.
No account needed: 5 free downloads a day (5 left today). Batch downloads and Office Action citations need a free account.
Patent office website: United States Patent and Trademark Office (USPTO)
Look up another patent
Need many patents at once?
Paste a whole list of numbers. DownloadPatent finds the right version of each and packs the PDFs into one ZIP.
Sign up free